ADAP - Adaptimmune GAAP EPS of -$0.04 revenue of $0.23M
2024-03-07 13:13:56 ET
More on Adaptimmune
- Adaptimmune Therapeutics plc (ADAP) Q4 2023 Earnings Call Transcript
- Adaptimmune: Drug Approval Now Imminent?
- FDA accepts Adaptimmune BLA for afami-cel, decision expected by Aug. 4
- Adaptimmune projects sarcoma franchise to deliver US peak year sales up to $400M
- Seeking Alpha’s Quant Rating on Adaptimmune